Pfizer To Pay $0 In Taxes Despite Raking In $58 Billion In Revenue Last Year

Big Pharma giant Pfizer are set to pay a grand total of $0 in taxes this year, despite raking in a mammoth $58 billion in revenue and net income during the financial year, and benefiting from enormous taxpayer funded subsidies.

Those who have been paying attention understand that Pfizer have been getting away with murder as the vaccinated and boosted continue dying suddenly and suffering rare and aggressive forms of cancer around the world.

But the news that Pfizer are also getting away without paying a cent in tax is particularly unsavory considering that Pfizer’s businesses are so heavily subsidized by taxpayer funded government grants.

How are they getting away with fleecing the taxpayers so shamelessly?

Every year, Pfizer sends an army of lobbyists to Washington, D.C., seeking to manipulate the tax code to their benefit.

Dossier reports: Thanks to their scale, size, and taxpayer-funded support system, Pfizer and its peers reap tax benefits that allow for the zeroing out of their tax burden. Such privileges are not afforded to Main Street businesses, highlighting an incredibly unequal tax code that benefits mega corporations at the expense of the average citizen and small businesses.

The news is especially unsavory for American taxpayers, considering the fact that Pfizer’s income over the course of the Covid era was produced via the American taxpayers themselves.

Taxpayers subsidized the research and development, approval process, purchasing, and implementation of Pfizer’s junk mRNA product line. The mRNA shots, coupled with the failed Paxlovid oral pill, gave Pfizer an unprecedented windfall, delivering tens of billions in annual profits.

Over the years, Pfizer has produced an incredibly extensive overseas tax shelter apparatus, one that includes hundreds of subsidiaries, which exist in over sixty different countries.

For many years, Pfizer — like many of its Fortune 100 peers — has offshored virtually all of its profits, effectively zeroing out its tax burden.

Although the company is headquartered in New York, Pfizer’s army of attorneys, accounts, and the like make sure to reorient their losses into the United States, while linking their profits to known tax shelter havens like Switzerland, Ireland, the British Virgin Islands, and Singapore.

And every year, Pfizer alone spends tens of millions of dollars lobbying legislators to manipulate the tax code to their benefit.

Last year, the pharmaceutical industry as a whole spent over $381 million to employ 1,851 lobbyists in Washington, D.C. And that work has paid major dividends for the mRNA giants.

Yet time and again, President Biden has made it a point to declare that his administration has pushed back against the interests of the pharmaceutical lobby, which spends more money lobbying in Washington, D.C. than any other industry.

In one such 2022 rally, President Biden screamed into the microphone, “we beat Pharma this year! We beat Pharma this year! And it mattered. We’re gonna change people’s lives.”

During his State of The Union address last month, Biden declared, “we finally beat Big Pharma … I also want to end the tax breaks for Big Pharma, Big Oil, private jets, and massive executive pay!”

Given Pfizer’s zero dollar tax burden, it sure doesn’t seem like Biden “beat Pharma” after all.